Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4830)
All Articles published online
|
Mar 26, 2012 (publication date) through May 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Affuso F, Mercurio V, Ruvolo A, Pirozzi C, Micillo F, Carlomagno G, Grieco F, Fazio S. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome. World J Cardiol 2012; 4(3): 77-83 [PMID: 22451856 DOI: 10.4330/wjc.v4.i3.77] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v4/i3/77.htm |
| Number | Citing Articles |
| 1 |
Rosa Solà, Rosa-M Valls, José Puzo, José-Ramón Calabuig, Angel Brea, Anna Pedret, David Moriña, José Villar, Jesús Millán, Anna Anguera, Alberico Catapano. Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial. PLoS ONE 2014; 9(8): e101978 doi: 10.1371/journal.pone.0101978
|
| 2 |
Ying Zhang, Jin Sun, Yun-Jiao Zhang, Qian-Yun Chai, Kang Zhang, Hong-Li Ma, Xiao-Ke Wu, Jian-Ping Liu. The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial. Trials 2016; 17(1) doi: 10.1186/s13063-016-1633-5
|
| 3 |
Ying Zhao, Yuan-Yuan Yang, Bao-Lin Yang, Ya-Wei Du, Da-Wei Ren, Hong-Mei Zhou, Jing Wang, Hui-Min Yang, Yao-Xian Wang, Ying-Ying Zhang, Sheng-Xian Wu. Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial. Trials 2021; 22(1) doi: 10.1186/s13063-021-05028-8
|
| 4 |
Anna Och, Marek Och, Renata Nowak, Dominika Podgórska, Rafał Podgórski. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules 2022; 27(4): 1351 doi: 10.3390/molecules27041351
|
| 5 |
Jacob A. Walker, Benjamin M. Dorsey, Marjorie A. Jones. Nutraceuticals and Natural Product Pharmaceuticals. 2019; : 167 doi: 10.1016/B978-0-12-816450-1.00006-4
|
| 6 |
Arrigo F. G. Cicero, Alessandra Reggi, Angelo Parini, Martino Morbini, Martina Rosticci, Elisa Grandi, Claudio Borghi. Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced Hypercholesterolemia. High Blood Pressure & Cardiovascular Prevention 2014; 21(3): 221 doi: 10.1007/s40292-014-0052-5
|
| 7 |
Dongdong Wang, Jiansheng Huang, Ting Gui, Yaxin Yang, Tingting Feng, Nikolay T. Tzvetkov, Tao Xu, Zhibo Gai, Ying Zhou, Jingjie Zhang, Atanas G. Atanasov. SR-BI as a target of natural products and its significance in cancer. Seminars in Cancer Biology 2022; 80: 18 doi: 10.1016/j.semcancer.2019.12.025
|
| 8 |
Angela Pirillo, Alberico Luigi Catapano. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Atherosclerosis 2015; 243(2): 449 doi: 10.1016/j.atherosclerosis.2015.09.032
|
| 9 |
S. Montserrat-de la Paz, M.D. García-Giménez, M. Ángel-Martín, M.C. Pérez-Camino, A. Fernández Arche. Long-chain fatty alcohols from evening primrose oil inhibit the inflammatory response in murine peritoneal macrophages. Journal of Ethnopharmacology 2014; 151(1): 131 doi: 10.1016/j.jep.2013.10.012
|
| 10 |
Andrew A. Bremer. Resveratrol Use in Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2014; 12(10): 493 doi: 10.1089/met.2014.1505
|
| 11 |
Giuseppe Derosa, Angela D'Angelo, Arianna Vanelli, Pamela Maffioli. <p>An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 653 doi: 10.2147/DMSO.S232791
|
| 12 |
Giuseppe Derosa, Pamela Maffioli. Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice. Expert Review of Endocrinology & Metabolism 2015; 10(3): 297 doi: 10.1586/17446651.2015.995630
|
| 13 |
Giuseppe Derosa, Angela D'Angelo, Pamela Maffioli. The role of selected nutraceuticals in management of prediabetes and diabetes: An updated review of the literature. Phytotherapy Research 2022; 36(10): 3709 doi: 10.1002/ptr.7564
|
| 14 |
Seema Patel. Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons. World Journal of Microbiology and Biotechnology 2016; 32(5) doi: 10.1007/s11274-016-2035-2
|
| 15 |
Muhammad Taher, Mohamad Shahreen Amri, Deny Susanti, Muhammad Badri Abdul Kudos, Anis Natasha Shafawi, Soraya Nur Yazid. Natural Bio-active Compounds. 2019; : 107 doi: 10.1007/978-981-13-7205-6_5
|
| 16 |
O. Sh. Oinotkinova, E. L. Nikonov, E. V. Kryukov, A. P. Baranov, M. I. Voevoda. Evolution of dyslipidemia: from etiological mechanisms to new targets of personalized preventive nutraceutical therapy with red yeast rice. Cardiovascular Therapy and Prevention 2019; 18(6): 88 doi: 10.15829/1728-8800-2019-6-88-98
|
| 17 |
Adrian V. Hernandez, Jennifer Hwang, Iram Nasreen, Dakota Sicignano, Vinay Pasupuleti, Kimberly Snow-Caroti, C. Michael White. Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis. Journal of Dietary Supplements 2024; 21(2): 242 doi: 10.1080/19390211.2023.2212762
|
| 18 |
Federica Fogacci, Maciej Banach, Dimitri P. Mikhailidis, Eric Bruckert, Peter P. Toth, Gerald F. Watts, Željko Reiner, John Mancini, Manfredi Rizzo, Olena Mitchenko, Daniel Pella, Zlatko Fras, Amirhossein Sahebkar, Michal Vrablik, Arrigo F.G. Cicero. Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 2019; 143: 1 doi: 10.1016/j.phrs.2019.02.028
|
| 19 |
Vivencio Barrios, Carlos Escobar, Arrigo Francesco Giuseppe Cicero, David Burke, Peter Fasching, Maciej Banach, Eric Bruckert. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence. Atherosclerosis Supplements 2017; 24: 1 doi: 10.1016/j.atherosclerosissup.2016.10.003
|
| 20 |
Jesus Millán, Arrigo F.G. Cicero, Francisco Torres, Anna Anguera. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials. Clínica e Investigación en Arteriosclerosis 2016; 28(4): 178 doi: 10.1016/j.arteri.2016.03.002
|
| 21 |
|
| 22 |
Paolo Bellavite, Serafino Fazio, Flora Affuso. A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention. Molecules 2023; 28(11): 4491 doi: 10.3390/molecules28114491
|
| 23 |
Giuseppe Derosa, Angela D'Angelo, Aldo Bonaventura, Lucio Bianchi, Davide Romano, Pamela Maffioli. Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert Opinion on Biological Therapy 2013; 13(4): 475 doi: 10.1517/14712598.2013.776037
|
| 24 |
Donporn Wongwaiwech, Monthana Weerawatanakorn, Panatpong Boonnoun. Subcritical dimethyl ether extraction as a simple method to extract nutraceuticals from byproducts from rice bran oil manufacture. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78011-z
|
| 25 |
Valentina Mercurio, Giacomo Pucci, Giorgio Bosso, Valeria Fazio, Francesca Battista, Angela Iannuzzi, Nadia Brambilla, Cristina Vitalini, Massimo D'Amato, Giampaolo Giacovelli, Gaetano Vaudo, Giuseppe Schillaci, Ferruccio Galletti, Domenico Bonaduce. A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trial. Clinical Nutrition 2020; 39(5): 1379 doi: 10.1016/j.clnu.2019.06.026
|
| 26 |
Mohammad Bagherniya, Hamed Khedmatgozar, Omid Fakheran, Suowen Xu, Thomas P. Johnston, Amirhossein Sahebkar. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome. Phytotherapy Research 2021; 35(9): 4804 doi: 10.1002/ptr.7118
|
| 27 |
Giuseppe Derosa, Pamela Maffioli, Arrigo FG Cicero. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opinion on Biological Therapy 2012; 12(8): 1113 doi: 10.1517/14712598.2012.704014
|
| 28 |
Luc E. Gosselin, Lauren Chrapowitzky, Todd C. Rideout. Metabolic effects of α-lipoic acid supplementation in pre-diabetics: a randomized, placebo-controlled pilot study. Food & Function 2019; 10(9): 5732 doi: 10.1039/C9FO00390H
|
| 29 |
Yanwen Wang, Jeffrey A. Zidichouski. Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis. Cholesterol 2018; 2018: 1 doi: 10.1155/2018/7173920
|
| 30 |
Serafino Fazio, Valentina Mercurio, Flora Affuso, Paolo Bellavite. The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment. Biomedicines 2023; 11(11): 2928 doi: 10.3390/biomedicines11112928
|
| 31 |
Arrigo F. G. Cicero, Alessandro Colletti. Combination Therapy In Dyslipidemia. 2015; : 127 doi: 10.1007/978-3-319-20433-8_11
|
| 32 |
Alireza Fatahian, Saeed Mohammadian Haftcheshmeh, Sara Azhdari, Helaleh Kaboli Farshchi, Banafsheh Nikfar, Amir Abbas Momtazi-Borojeni. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology 2020; 178: 83 doi: 10.1007/112_2020_42
|
| 33 |
Touqeer Ahmed, Anwar-ul-Hassan Gilani, Mohammad Abdollahi, Maria Daglia, Seyed Fazel Nabavi, Seyed Mohammad Nabavi. Berberine and neurodegeneration: A review of literature. Pharmacological Reports 2015; 67(5): 970 doi: 10.1016/j.pharep.2015.03.002
|
| 34 |
Matteo Pirro, Massimo Raffaele Mannarino, Vanessa Bianconi, Luis E. Simental-Mendía, Francesco Bagaglia, Elmo Mannarino, Amirhossein Sahebkar. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta -analysis of randomized controlled trials. Pharmacological Research 2016; 110: 76 doi: 10.1016/j.phrs.2016.04.021
|
| 35 |
Felix Zulhendri, Munir Ravalia, Krishna Kripal, Kavita Chandrasekaran, James Fearnley, Conrad O. Perera. Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review. Antioxidants 2021; 10(3): 348 doi: 10.3390/antiox10030348
|
| 36 |
Gong Chen, Wanbo Chen, Jinhong Xu, Guodong Ma, Xinge Hu, Guoxun Chen. The current trend and challenges of developing red yeast rice-based food supplements for hypercholesterolemia. Journal of Future Foods 2023; 3(4): 312 doi: 10.1016/j.jfutfo.2023.03.003
|
| 37 |
Shu-Jun FENG, Zhi-Han TANG, Ying WANG, Xin-Ying TANG, Tao-Hua LI, Wei TANG, Ze-Min KUANG. Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular disease. Chinese Journal of Natural Medicines 2019; 17(1): 50 doi: 10.1016/S1875-5364(19)30009-3
|
| 38 |
Junjun Shen, Feijun Luo, Qinlu Lin. Policosanol: Extraction and biological functions. Journal of Functional Foods 2019; 57: 351 doi: 10.1016/j.jff.2019.04.024
|
| 39 |
Pan Xiong, Li Niu, Sam Talaei, Hamed Kord-Varkaneh, Cain C.T. Clark, Mihnea-Alexandru Găman, Jamal Rahmani, Masoumeh Dorosti, Seyed Mohammad Mousavi, Meysam Zarezadeh, Hossein Taghizade-Bilondi, Jitao Zhang. The effect of berberine supplementation on obesity indices: A dose– response meta-analysis and systematic review of randomized controlled trials. Complementary Therapies in Clinical Practice 2020; 39: 101113 doi: 10.1016/j.ctcp.2020.101113
|
| 40 |
Brenda De la Cruz-Concepción, Yaccil Adilene Flores-Cortez, Martha Isela Barragán-Bonilla, Juan Miguel Mendoza-Bello, Monica Espinoza-Rojo. Insulin: A connection between pancreatic β cells and the hypothalamus. World Journal of Diabetes 2023; 14(2): 76-91 doi: 10.4239/wjd.v14.i2.76
|
| 41 |
Giuseppe Marazzi, Francesco Pelliccia, Giuseppe Campolongo, Silvia Quattrino, Luca Cacciotti, Maurizio Volterrani, Carlo Gaudio, Giuseppe Rosano. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease. The American Journal of Cardiology 2015; 116(12): 1798 doi: 10.1016/j.amjcard.2015.09.023
|
| 42 |
Karina G. Pérez-Rubio, Manuel González-Ortiz, Esperanza Martínez-Abundis, José A. Robles-Cervantes, María C. Espinel-Bermúdez. Effect of Berberine Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. Metabolic Syndrome and Related Disorders 2013; 11(5): 366 doi: 10.1089/met.2012.0183
|
| 43 |
Isabel De Castro-Orós, Rosa Solà, Rosa María Valls, Angel Brea, Pilar Mozas, Jose Puzo, Miguel Pocoví, Maria Cristina Vinci. Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine. PLOS ONE 2016; 11(3): e0150785 doi: 10.1371/journal.pone.0150785
|
| 44 |
Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. Complementary and Alternative Medicine. 2019; : 125 doi: 10.4018/978-1-5225-7039-4.ch006
|
| 45 |
Mark Houston. The role of nutrition and nutritional supplements in the treatment of dyslipidemia. Clinical Lipidology 2014; 9(3): 333 doi: 10.2217/clp.14.25
|
| 46 |
Kyung-Hyun Cho. High-Density Lipoproteins as Biomarkers and Therapeutic Tools. 2019; : 115 doi: 10.1007/978-981-13-7383-1_3
|
| 47 |
Arrigo F. G. Cicero, Cormac Kennedy, Tamara Knežević, Marilisa Bove, Coralie M. G. Georges, Agnė Šatrauskienė, Peter P. Toth, Federica Fogacci. Efficacy and Safety of Armolipid Plus®: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Nutrients 2021; 13(2): 638 doi: 10.3390/nu13020638
|
| 48 |
Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. Recent Advances in Drug Delivery Technology. Advances in Medical Technologies and Clinical Practice 2017; : 160 doi: 10.4018/978-1-5225-0754-3.ch006
|
| 49 |
Yaping Zhou, Fuliang Cao, Feijun Luo, Qinlu Lin. Octacosanol and health benefits: Biological functions and mechanisms of action. Food Bioscience 2022; 47: 101632 doi: 10.1016/j.fbio.2022.101632
|
| 50 |
Elias Sanidas, Charalampos Grassos. The role of nutraceuticals in the treatment of primary dyslipidemia. Hellenic Journal of Cardiology 2020; 61(1): 60 doi: 10.1016/j.hjc.2018.07.009
|
| 51 |
Yan Li, Hongli Ma, Yuehui Zhang, Hongying Kuang, Ernest Hung Yu Ng, Lihui Hou, Xiaoke Wu. Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial. Trials 2013; 14(1) doi: 10.1186/1745-6215-14-226
|
| 52 |
Seema Patel, Nadeem Akhtar. Fungi and their Role in Sustainable Development: Current Perspectives. 2018; : 739 doi: 10.1007/978-981-13-0393-7_38
|
| 53 |
Xiao-Ke Wu, Ernest HY Ng. Infertility in Women with Polycystic Ovary Syndrome. 2018; : 181 doi: 10.1007/978-3-319-45534-1_14
|
| 54 |
Stefano Gonnelli, Carla Caffarelli, Kostantinos Stolakis, Claudia Cuda, Nicola Giordano, Ranuccio Nuti. Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study. Current Therapeutic Research 2015; 77: 1 doi: 10.1016/j.curtheres.2014.07.003
|
| 55 |
Vanessa Bianconi, Massimo Raffaele Mannarino, Amirhossein Sahebkar, Teresa Cosentino, Matteo Pirro. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk. Current Cardiology Reports 2018; 20(7) doi: 10.1007/s11886-018-0994-7
|
| 56 |
Miriam Méndez-del Villar, Manuel González-Ortiz, Esperanza Martínez-Abundis, Karina G. Pérez-Rubio, Roberto Lizárraga-Valdez. Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. Metabolic Syndrome and Related Disorders 2014; 12(10): 497 doi: 10.1089/met.2014.0082
|
| 57 |
Arrigo Fg Cicero, Elisa Tartagni, Claudio Borghi. Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction?. Clinical Lipidology 2012; 7(5): 549 doi: 10.2217/clp.12.55
|